CalciMedica Shareholders Back Expansion and Elect Directors
Company Announcements

CalciMedica Shareholders Back Expansion and Elect Directors

An announcement from CalciMedica (CALC) is now available.

CalciMedica, Inc. stockholders convened for the 2024 Annual Meeting, endorsing a key amendment to increase the authorized stock issuance under the company’s 2023 Equity Incentive Plan by 1.5 million shares. Additionally, they elected two Class I directors for a three-year term and ratified the appointment of Moss Adams LLP as the principal independent auditor for the upcoming fiscal year. These decisions reflect shareholders’ active participation in shaping the company’s strategic incentives and governance.

Learn more about CALC stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyCalciMedica director buys $201K in common stock
TheFlyCalciMedica reports $19.1M in cash, equivalents
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App